Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | KCNB1 | Q14721 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.43 |
| ▸ | TP53 | P04637 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | NR2E3 | Q9Y5X4 | 2/20 | 0.43 |
| ▸ | KLK7 | P49862 | 1/20 | 0.43 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6091959 | 0.86 | LMNA (0.53) | KCNB1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL6094823 | 0.86 | LMNA (0.53) | KCNB1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL4363672 | 0.84 | FFAR2 (0.55) | KMT2A | |
| SCHEMBL6092098 | 0.83 | HSD17B10 (0.46) | ADORA2AALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL6096686 | 0.79 | EPHX1 (0.48) | ALDH1A1KDM4EHPGDHSD17B10TP53 | |
| SCHEMBL4372959 | 0.79 | KDM4E (0.44) | ALDH1A1KDM4EHPGDHSD17B10TP53 | |
| SCHEMBL2242067 | 0.78 | NR2E3 (0.60) | ALDH1A1KDM4EHPGDHSD17B10TP53 | |
| SCHEMBL4371236 | 0.78 | ROCK2 (0.47) | ADORA2AALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL4367691 | 0.78 | ALDH1A1 (0.48) | ALDH1A1KDM4EHPGDHSD17B10TP53 | |
| SCHEMBL4365497 | 0.77 | MAPT (0.45) | ALDH1A1KDM4EHPGDTP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10813914-B2 | Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same | MARUHA NICHIRO CORPORATION (JP) | 2020-10-27 | — | — | US | disclosed |
| US-20190111027-A1 | COMPOSITION FOR CONTROLLING MICROSPORIDIA IN FISHES AND METHOD FOR CONTROLLING MICROSPORIDIA IN FISHES USING SAME | MARUHA NICHIRO CORPORATION (JP) | 2019-04-18 | — | — | US | disclosed |
| EP-3437642-A1 | COMPOSITION FOR CONTROLLING MICROSPORIDIA IN FISHES AND METHOD FOR CONTROLLING MICROSPORIDIA IN FISHES USING SAME | Maruha Nichiro Corporation (JP) | 2019-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10813914-B2 | Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same | MUSK, MRM1, RRS1 | ADORA2A 3874/4885NPSR1 430/4885KCNB1 1071/4885 |
| US-20190111027-A1 | COMPOSITION FOR CONTROLLING MICROSPORIDIA IN FISHES AND METHOD FOR CONTROLLING MICROSPORIDIA IN FISHES USING SAME | MUSK, MRM1, RRS1 | ADORA2A 3874/4885NPSR1 430/4885KCNB1 1071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.